Portfolio (Quarterly)
Guide ↗
BRAIDWELL LP
· CIK 0001920938| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CAI | CARIS LIFE SCIENCES INC | Healthcare | 7,816,142.0 | $210.9M | 6.74% | +500K | +6.8% | $26.98 | -46.1% |
| 2 | — | GUARDANT HEALTH INC | — | 104,854,000.0 | $192.3M | 6.15% | -114.6M | -52.2% | $1.83 | — |
| 3 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 5,210,831.0 | $129.3M | 4.13% | — | — | $24.81 | +37.1% |
| 4 | — | REPLIGEN CORP | — | 101,000,000.0 | $110.8M | 3.54% | — | — | $1.10 | — |
| 5 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 751,534.0 | $106.6M | 3.41% | -129K | -14.6% | $141.83 | +12.1% |
| 6 | GKOS | GLAUKOS CORP | Healthcare | 921,979.0 | $104.1M | 3.33% | +142K | +18.2% | $112.91 | +25.9% |
| 7 | — | NEOGENOMICS INC | — | 100,381,000.0 | $89.7M | 2.87% | — | — | $0.89 | — |
| 8 | NUVL | NUVALENT INC | Healthcare | 821,406.0 | $82.6M | 2.64% | -192K | -18.9% | $100.59 | +3.8% |
| 9 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 1,825,076.0 | $81.8M | 2.62% | -1.8M | -49.4% | $44.82 | +24.9% |
| 10 | CGON | CG ONCOLOGY INC | Healthcare | 1,870,571.0 | $77.7M | 2.48% | -1.4M | -43.0% | $41.52 | +61.2% |
| 11 | — | IRHYTHM TECHNOLOGIES INC | — | 52,000,000.0 | $72.8M | 2.33% | -10.0M | -16.1% | $1.40 | — |
| 12 | HNGE | HINGE HEALTH INC | Healthcare | 1,304,623.0 | $60.6M | 1.94% | +394K | +43.3% | $46.45 | +16.0% |
| 13 | ALGN | ALIGN TECHNOLOGY INC | Healthcare | 381,004.0 | $59.5M | 1.90% | -29K | -7.0% | $156.15 | +0.7% |
| 14 | KOD | KODIAK SCIENCES INC | Healthcare | 2,072,788.0 | $58.0M | 1.85% | NEW | — | $27.96 | +38.4% |
| 15 | — | SOLENO THERAPEUTICS INC | — | 1,187,859.0 | $55.0M | 1.76% | -94K | -7.3% | $46.30 | — |
| 16 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 2,188,320.0 | $54.7M | 1.75% | NEW | — | $25.01 | +58.3% |
| 17 | NEO | NEOGENOMICS INC | Healthcare | 4,632,801.0 | $54.5M | 1.74% | +2.9M | +161.6% | $11.76 | -28.9% |
| 18 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 2,032,021.0 | $54.3M | 1.74% | -347K | -14.6% | $26.71 | -19.9% |
| 19 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 1,634,615.0 | $53.5M | 1.71% | -944K | -36.6% | $32.76 | +130.9% |
| 20 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 1,273,935.0 | $52.5M | 1.68% | +439K | +52.6% | $41.21 | +107.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%